Express Scripts (ESRX) was downgraded to sell from hold at Credit Suisse. $61 price target. Troubles with Anthem will likely have a material earnings impact, Credit Suisse said.
First Republic (FRC - Get Report) was upgraded to buy from hold at Jefferies. $70 price target. Costs are moderating, and the company is seeing higher wealth management revenue and loan growth, Jefferies said.
WellCare was upgraded to neutral from underperform at Bank of America/Merrill Lynch. $94 price target. The company has multiple potential growth catalysts, analysts said.